Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma

Background: Recent advances in the development of tyrosine kinase inhibitors (TKIs) have enabled patients with unresectable hepatocellular carcinoma (HCC) to receive multiple TKIs in sequence. The aim of this study was to identify predictors of good candidates for second-line treatment after disease...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Cancers (Basel)
Main Authors: Takada, Hitomi, Kurosaki, Masayuki, Tsuchiya, Kaoru, Komiyama, Yasuyuki, Itakura, Jun, Takahashi, Yuka, Nakanishi, Hiroyuki, Yasui, Yutaka, Tamaki, Nobuharu, Maeyashiki, Chiaki, Kaneko, Shun, Takaura, Kenta, Higuchi, Mayu, Okada, Mao, Wang, Wan, Osawa, Leona, Sekiguchi, Shuhei, Hayakawa, Yuka, Yamashita, Koji, Enomoto, Nobuyuki, Izumi, Namiki
Formáid: Artigo
Teanga:Inglês
Foilsithe: MDPI 2019
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6770447/
https://ncbi.nlm.nih.gov/pubmed/31461985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11091256
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla